BETHLEHEM, Pa., September 24, 2021– (BUSINESS WIRE) – Dr. Salvatore J. Salamone obtained the prestigious Dr. CE Pippenger Award at the 2021 Annual Assembly of the Worldwide Affiliation for Therapeutic Drug Surveillance and Scientific Toxicology (IATDMCT) held in Rome, Italy. This award is given to people who’ve made excellent contributions in the area of therapeutic drug monitoring (TDM). TDM is a area of medical science that seeks to make sure that sufferers obtain a personalised dose of treatment to attain an optimum therapeutic outcome. Sadly, many medication, corresponding to anticancer medication, antibiotics, and antifungal remedies, have extreme toxicities when overdosed and are ineffective when underdosed. TDM tries to make sure that the affected person receives sufficient drug to deal with the illness, however not an excessive amount of to trigger toxicities and probably demise.
This press launch is about multimedia. See the full information right here: https://www.businesswire.com/information/house/20210923006020/es/
Dr. Salvatore J. Salamone (Picture: Enterprise Wire)
Dr. Salamone obtained this award for his contributions to TDM in oncology. He started engaged on the GDT of most cancers medication after witnessing opposed reactions brought on by toxicity throughout chemotherapy remedy of his relations. It was proposed that no affected person ever obtain anticancer medication with out GDT guaranteeing an ample dose. He has championed the institution of medical pointers for GDT and pharmacology in oncology for greater than 15 years.
Dr. Salamone accepted this award as an important honor and paid tribute to the affect that Dr. Pippenger had in the area of TDM and on him personally. With over 30 years of expertise in diagnostic growth, Dr. Salamone is world famend in the area of drug monitoring and has printed extensively on this space. In his acceptance speech, Dr. Salamone mentioned the vital function that TDM performs in personalised drugs.
Learn extra
Dr. Salamone went on to explain that the “unlucky actuality in oncology is that many, if not most, sufferers should not receiving the appropriate dose of chemotherapy and we now have to behave.” Dr. Salamone continued: “Sufferers are unnecessarily struggling opposed results as a result of the dose is simply too excessive, whereas others should not receiving sufficient drug to deal with most cancers successfully.” Utilizing the normal physique floor space (BSA) dosing technique, developed in 1916, to ship chemotherapy has change into out of date. Welcome to the 21st century. “He described the lack of information and resistance to MDD by the oncology neighborhood.” I urge all members of the IATDMCT to be extra lively in participating the oncology neighborhood, “acknowledged Dr. Salamone. “Receiving this award evokes me to proceed to pursue my purpose of creating GDT the normal of care in oncology.”
“We won’t totally notice the promise of personalised drugs till every affected person receives the right amount of drug for his or her physique,” mentioned Dr. Salamone. “As the first particular person in the trade to obtain this prestigious award, I’m deeply honored and excited that my life’s work has been acknowledged by such an esteemed group.”
ABOUT SALADAX BIOMEDICAL, INC.
Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held firm that develops, manufactures, and markets assays that present fast therapeutic ranges of life-saving and important medication prescribed by psychiatrists and oncologists. Since 2007, Saladax’s patented expertise has been utilized in medical laboratories or at level of care to assist physicians monitor and optimize affected person care, go to Saladax.com
For extra info, go to Saladax.com or MyCareTests.com.
The unique textual content in the supply language of this launch is the official approved model. Translations are offered as an adaptation solely and have to be checked in opposition to the textual content in the supply language, which is the solely model of the textual content that may have authorized impact.
View the unique model at businesswire.com: https://www.businesswire.com/information/house/20210923006020/en/
Contacts
Saladax Biomedical, Inc.
Salvatore Salamone, Ph.D., 610-419-6731
[email protected]
Add Comment